Abstract
While the precise mode of action of artemisinin (ART) derivatives remains obscure, it is nonetheless commonly accepted that ART generates reactive oxygen intermediates that contribute to cell death. Also, numerous studies confirm that point mutations in the propeller domain of K13 protein play a key role in resistance to ART derivatives. Because of its homology with the KEAP1 protein, it is thought that this protein may have a role in the polyubiquitination of proteins and that its alteration may cause resistance of young parasite stages to the drug. In this chapter, we present our current knowledge of K13-related resistance to ART and its spread in Southeast Asia and discuss its possible emergence and/or diffusion in Africa.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Noedl H, Se Y, Schaecher K et al (2008) Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359:2619–2620
Dondorp AM, Nosten F, Yi P et al (2009) Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361:455–467
Mita T, Tanabe K, Kita K (2009) Spread and evolution of Plasmodium falciparum drug resistance. Parasitol Int 58:201–209
Ariey F, Witkowski B, Amaratunga C et al (2014) A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505:50–55
Straimer J, Gnädig NF, Witkowski B et al (2015) Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science 347:428–431
Mbengue A, Bhattacharjee S, Pandharkar T et al (2015) A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature 520:683–687
Ménard D, Khim N, Beghain J et al (2016) A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med 374:2453–2464
Antoine T, Fisher N, Amewu R et al (2014) Rapid kill of malaria parasites by artemisinin and semi-synthetic endoperoxides involves ROS-dependent depolarization of the membrane potential. J Antimicrob Chemother 69:1005–1016
Hu W, Chen SS, Zhang JL et al (2014) Dihydroartemisinin induces autophagy by suppressing NF-κB activation. Cancer Lett 343:239–248
Efferth T, Giaisi M, Merling A et al (2007) Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells. PLoS One 2:e693
Kiefer CR, Snyder LM (2000) Oxidation and erythrocyte senescence. Curr Opin Hematol 7:113–116
O’Neill PM, Gary HP (2004) A medicinal chemistry perspective on artemisinin and related endoperoxides. J Med Chem 47:2945–2964
Kumura N, Furukawa H, Onyango AN et al (2009) Different behavior of artemisinin and tetraoxane in the oxidative degradation of phospholipid. Chem Phys Lipids 160:114–120
Wang J, Zhang CJ, Chia WN et al (2015) Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum. Nat Commun 6:10111
Bridgford JL, Xie SC, Cobbold SA et al (2018) Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome. Nat Commun 9:3801
Itoh K, Wakabayashi N, Katoh Y et al (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13:76–86
Mok S, Ashley EA, Ferreira PE et al (2015) Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance. Science 347:431–435
Dogovski C, Xie SC, Burgio G et al (2015) Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance. PLoS Biol 13:e1002132
Kyle DE, Webster HK (1996) Postantibiotic effect of quinine and dihydroartemisinin on Plasmodium falciparum in vitro: implications for a mechanism of recrudescence. In: XIVth International Congress for Tropical Medicine and Malaria
Teuscher F, Gatton ML, Chen N et al (2010) Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure. J Infect Dis 202:1362–1368
Witkowski B, Lelièvre J, Barragán MJ et al (2010) Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. Antimicrob Agents Chemother 54:1872–1877
Witkowski B, Amaratunga C, Khim N et al (2013) Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis 13:1043–1049
Witkowski B, Khim N, Chim P et al (2013) Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob Agents Chemother 57:914–923
Mok S, Imwong M, Mackinnon MJ et al (2011) Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics 12:391
Zhang M, Gallego-Delgado J, Fernandez-Arias C et al (2017) Inhibiting the Plasmodium eIF2a kinase PK4 prevents artemisinin-induced latency. Cell Host Microbe 22:766–776
Wootton JC, Feng X, Ferdig MT et al (2002) Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418:320–323
Imwong M, Suwannasin K, Kunasol C et al (2017) The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis 17:491–497
Amato R, Pearson RD, Almagro-Garcia J et al (2018) Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study. Lancet Infect Dis 18:337–345
Phyo AP, Ashley EA, Anderson TJC et al (2016) Declining efficacy of artemisinin combination therapy against P. falciparum malaria on the Thai-Myanmar border (2003-2013): the role of parasite genetic factors. Clin Infect Dis 63:784–791
Witkowski B, Duru V, Khim N et al (2017) A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study. Lancet Infect Dis 17:174–183
Ariey F, Fandeur T, Durand R et al (2006) Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J 5:34
Maïga O, Djimdé AA, Hubert V et al (2007) A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. J Infect Dis 196:165–172
Vinayak S, Alam MT, Mixson-Hayden T et al (2010) Origin and evolution of sulfadoxine resistant Plasmodium falciparum. PLoS Pathog 6:e1000830
Tatem AJ, Smith DL (2010) International population movements and regional Plasmodium falciparum malaria elimination strategies. Proc Natl Acad Sci U S A 107:12222–12227
Ariey F, Robert V (2003) The puzzling links between malaria transmission and drug resistance. Trends Parasitol 19:158–160
Scott N, Ataide R, Wilson DP et al (2018) Implications of population-level immunity for the emergence of artemisinin-resistant malaria: a mathematical model. Malar J 17:279
Zani B, Gathu M, Donegan S et al (2014) Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst Rev (1):CD010927
Sutherland CJ, Lansdell P, Sanders M et al (2017) pfk13-independent treatment failure in four imported cases of Plasmodium falciparum malaria treated with artemether-lumefantrine in the United Kingdom. Antimicrob Agents Chemother 61. https://doi.org/10.1128/AAC.02382-16
Ikeda M, Kaneko M, Tachibana SI et al (2018) Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014-2016. Emerg Infect Dis 24:718–726
Lu F, Culleton R, Zhang M et al (2017) Emergence of indigenous artemisinin-resistant Plasmodium falciparum in Africa. N Engl J Med 376:991–993
Rocamora F, Zhu L, Liong KY et al (2018) Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites. PLoS Pathog 14:e1006930
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Ariey, F., Ménard, D. (2019). An Update on Artemisinin Resistance. In: Ariey, F., Gay, F., Ménard, R. (eds) Malaria Control and Elimination. Methods in Molecular Biology, vol 2013. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9550-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9550-9_10
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9549-3
Online ISBN: 978-1-4939-9550-9
eBook Packages: Springer Protocols